A  ||| S:0 E:2 ||| DT
multi-species  ||| S:2 E:16 ||| JJ
comparative  ||| S:16 E:28 ||| JJ
structural  ||| S:28 E:39 ||| JJ
bioinformatics  ||| S:39 E:54 ||| JJ
analysis  ||| S:54 E:63 ||| NN
of  ||| S:63 E:66 ||| IN
inherited  ||| S:66 E:76 ||| JJ
mutations  ||| S:76 E:86 ||| NNS
in  ||| S:86 E:89 ||| IN
alpha-D-mannosidase  ||| S:89 E:109 ||| NNP
reveals  ||| S:109 E:117 ||| VBZ
strong  ||| S:117 E:124 ||| JJ
genotype-phenotype  ||| S:124 E:143 ||| JJ
correlation  ||| S:143 E:155 ||| NN
Lysosomal  ||| S:155 E:165 ||| NNP
alpha-mannosidase  ||| S:165 E:183 ||| NNP
is  ||| S:183 E:186 ||| VBZ
an  ||| S:186 E:189 ||| DT
enzyme  ||| S:189 E:196 ||| NN
that  ||| S:196 E:201 ||| WDT
acts  ||| S:201 E:206 ||| VBZ
to  ||| S:206 E:209 ||| TO
degrade  ||| S:209 E:217 ||| VB
N-linked  ||| S:217 E:226 ||| JJ
oligosaccharides  ||| S:226 E:243 ||| NN
and  ||| S:243 E:247 ||| CC
hence  ||| S:247 E:253 ||| RB
plays  ||| S:253 E:259 ||| VBZ
an  ||| S:259 E:262 ||| DT
important  ||| S:262 E:272 ||| JJ
role  ||| S:272 E:277 ||| NN
in  ||| S:277 E:280 ||| IN
mannose  ||| S:280 E:288 ||| JJ
metabolism  ||| S:288 E:299 ||| NN
in  ||| S:299 E:302 ||| IN
humans  ||| S:302 E:309 ||| NNS
and  ||| S:309 E:313 ||| CC
other  ||| S:313 E:319 ||| JJ
mammalian  ||| S:319 E:329 ||| JJ
species ||| S:329 E:336 ||| NNS
,  ||| S:336 E:338 ||| ,
especially  ||| S:338 E:349 ||| RB
livestock ||| S:349 E:358 ||| VBN
.  ||| S:358 E:360 ||| .
Mutations  ||| S:360 E:370 ||| NNS
in  ||| S:370 E:373 ||| IN
the  ||| S:373 E:377 ||| DT
gene  ||| S:377 E:382 ||| NN
( ||| S:382 E:383 ||| -LRB-
MAN2B1 ||| S:383 E:389 ||| NNP
)  ||| S:389 E:391 ||| -RRB-
encoding  ||| S:391 E:400 ||| FW
lysosomal  ||| S:400 E:410 ||| FW
alpha-D-mannosidase  ||| S:410 E:430 ||| FW
cause  ||| S:430 E:436 ||| FW
improper  ||| S:436 E:445 ||| FW
coding ||| S:445 E:451 ||| FW
,  ||| S:451 E:453 ||| ,
resulting  ||| S:453 E:463 ||| VBG
in  ||| S:463 E:466 ||| IN
dysfunctional  ||| S:466 E:480 ||| NN
or  ||| S:480 E:483 ||| CC
non-functional  ||| S:483 E:498 ||| JJ
protein ||| S:498 E:505 ||| NN
,  ||| S:505 E:507 ||| ,
causing  ||| S:507 E:515 ||| VBG
the  ||| S:515 E:519 ||| DT
disease  ||| S:519 E:527 ||| NN
alpha-mannosidosis ||| S:527 E:545 ||| NN
.  ||| S:545 E:547 ||| .
Mapping  ||| S:547 E:555 ||| JJ
disease  ||| S:555 E:563 ||| NN
mutations  ||| S:563 E:573 ||| NNS
to  ||| S:573 E:576 ||| TO
the  ||| S:576 E:580 ||| DT
structure  ||| S:580 E:590 ||| NN
of  ||| S:590 E:593 ||| IN
the  ||| S:593 E:597 ||| DT
protein  ||| S:597 E:605 ||| NN
can  ||| S:605 E:609 ||| MD
help  ||| S:609 E:614 ||| VB
in  ||| S:614 E:617 ||| IN
understanding  ||| S:617 E:631 ||| VBG
the  ||| S:631 E:635 ||| DT
functional  ||| S:635 E:646 ||| JJ
consequences  ||| S:646 E:659 ||| NNS
of  ||| S:659 E:662 ||| IN
these  ||| S:662 E:668 ||| DT
mutations  ||| S:668 E:678 ||| NN
and  ||| S:678 E:682 ||| CC
thus  ||| S:682 E:687 ||| RB
indirectly ||| S:687 E:697 ||| RB
,  ||| S:697 E:699 ||| ,
the  ||| S:699 E:703 ||| DT
finer  ||| S:703 E:709 ||| JJ
aspects  ||| S:709 E:717 ||| NNS
of  ||| S:717 E:720 ||| IN
the  ||| S:720 E:724 ||| DT
pathology  ||| S:724 E:734 ||| NN
and  ||| S:734 E:738 ||| CC
clinical  ||| S:738 E:747 ||| JJ
manifestations  ||| S:747 E:762 ||| NNS
of  ||| S:762 E:765 ||| IN
the  ||| S:765 E:769 ||| DT
disease ||| S:769 E:776 ||| NN
,  ||| S:776 E:778 ||| ,
including  ||| S:778 E:788 ||| VBG
phenotypic  ||| S:788 E:799 ||| JJ
severity  ||| S:799 E:808 ||| NN
as  ||| S:808 E:811 ||| IN
a  ||| S:811 E:813 ||| DT
function  ||| S:813 E:822 ||| NN
of  ||| S:822 E:825 ||| IN
the  ||| S:825 E:829 ||| DT
genotype ||| S:829 E:837 ||| NN
.  ||| S:837 E:839 ||| .
A  ||| S:839 E:841 ||| DT
comprehensive  ||| S:841 E:855 ||| JJ
homology  ||| S:855 E:864 ||| JJ
modeling  ||| S:864 E:873 ||| JJ
study  ||| S:873 E:879 ||| NN
of  ||| S:879 E:882 ||| IN
all  ||| S:882 E:886 ||| PDT
the  ||| S:886 E:890 ||| DT
wild-type  ||| S:890 E:900 ||| JJ
and  ||| S:900 E:904 ||| CC
inherited  ||| S:904 E:914 ||| VBD
mutations  ||| S:914 E:924 ||| VBN
of  ||| S:924 E:927 ||| IN
lysosomal  ||| S:927 E:937 ||| JJ
alpha-mannosidase  ||| S:937 E:955 ||| NN
in  ||| S:955 E:958 ||| IN
four  ||| S:958 E:963 ||| CD
different  ||| S:963 E:973 ||| JJ
species ||| S:973 E:980 ||| NNS
,  ||| S:980 E:982 ||| ,
human ||| S:982 E:987 ||| JJ
,  ||| S:987 E:989 ||| ,
cow ||| S:989 E:992 ||| NN
,  ||| S:992 E:994 ||| ,
cat  ||| S:994 E:998 ||| NN
and  ||| S:998 E:1002 ||| CC
guinea  ||| S:1002 E:1009 ||| JJ
pig ||| S:1009 E:1012 ||| NN
,  ||| S:1012 E:1014 ||| ,
reveals  ||| S:1014 E:1022 ||| VBZ
a  ||| S:1022 E:1024 ||| DT
significant  ||| S:1024 E:1036 ||| JJ
correlation  ||| S:1036 E:1048 ||| NN
between  ||| S:1048 E:1056 ||| IN
the  ||| S:1056 E:1060 ||| DT
severity  ||| S:1060 E:1069 ||| NN
of  ||| S:1069 E:1072 ||| IN
the  ||| S:1072 E:1076 ||| DT
genotype  ||| S:1076 E:1085 ||| NN
and  ||| S:1085 E:1089 ||| CC
the  ||| S:1089 E:1093 ||| DT
phenotype  ||| S:1093 E:1103 ||| NN
in  ||| S:1103 E:1106 ||| IN
alpha-mannosidosis ||| S:1106 E:1124 ||| JJ
.  ||| S:1124 E:1126 ||| .
We  ||| S:1126 E:1129 ||| PRP
used  ||| S:1129 E:1134 ||| VBD
the  ||| S:1134 E:1138 ||| DT
X-ray  ||| S:1138 E:1144 ||| NN
crystallographic  ||| S:1144 E:1161 ||| NN
structure  ||| S:1161 E:1171 ||| NN
of  ||| S:1171 E:1174 ||| IN
bovine  ||| S:1174 E:1181 ||| JJ
lysosomal  ||| S:1181 E:1191 ||| JJ
alpha-mannosidase  ||| S:1191 E:1209 ||| NN
as  ||| S:1209 E:1212 ||| IN
template ||| S:1212 E:1220 ||| NN
,  ||| S:1220 E:1222 ||| ,
containing  ||| S:1222 E:1233 ||| VBG
only  ||| S:1233 E:1238 ||| RB
two  ||| S:1238 E:1242 ||| CD
disulphide  ||| S:1242 E:1253 ||| CD
bonds  ||| S:1253 E:1259 ||| NNS
and  ||| S:1259 E:1263 ||| CC
some  ||| S:1263 E:1268 ||| DT
ligands ||| S:1268 E:1275 ||| NN
,  ||| S:1275 E:1277 ||| ,
to  ||| S:1277 E:1280 ||| TO
build  ||| S:1280 E:1286 ||| VB
structural  ||| S:1286 E:1297 ||| JJ
models  ||| S:1297 E:1304 ||| NNS
of  ||| S:1304 E:1307 ||| IN
wild-type  ||| S:1307 E:1317 ||| JJ
structures  ||| S:1317 E:1328 ||| NNS
with  ||| S:1328 E:1333 ||| IN
four  ||| S:1333 E:1338 ||| CD
disulfide  ||| S:1338 E:1348 ||| CD
linkages  ||| S:1348 E:1357 ||| NNS
and  ||| S:1357 E:1361 ||| CC
all  ||| S:1361 E:1365 ||| DT
bound  ||| S:1365 E:1371 ||| JJ
ligands ||| S:1371 E:1378 ||| NN
.  ||| S:1378 E:1380 ||| .
These  ||| S:1380 E:1386 ||| DT
wild-type  ||| S:1386 E:1396 ||| JJ
models  ||| S:1396 E:1403 ||| NNS
were  ||| S:1403 E:1408 ||| VBD
then  ||| S:1408 E:1413 ||| RB
used  ||| S:1413 E:1418 ||| VBN
as  ||| S:1418 E:1421 ||| IN
templates  ||| S:1421 E:1431 ||| NN
for  ||| S:1431 E:1435 ||| IN
disease  ||| S:1435 E:1443 ||| NN
mutations ||| S:1443 E:1452 ||| NNS
.  ||| S:1452 E:1454 ||| .
All  ||| S:1454 E:1458 ||| PDT
the  ||| S:1458 E:1462 ||| DT
truncations  ||| S:1462 E:1474 ||| NN
and  ||| S:1474 E:1478 ||| CC
substitutions  ||| S:1478 E:1492 ||| VBP
involving  ||| S:1492 E:1502 ||| VBG
the  ||| S:1502 E:1506 ||| DT
residues  ||| S:1506 E:1515 ||| NN
in  ||| S:1515 E:1518 ||| IN
and  ||| S:1518 E:1522 ||| CC
around  ||| S:1522 E:1529 ||| IN
the  ||| S:1529 E:1533 ||| DT
active  ||| S:1533 E:1540 ||| JJ
site  ||| S:1540 E:1545 ||| NN
and  ||| S:1545 E:1549 ||| CC
those  ||| S:1549 E:1555 ||| DT
that  ||| S:1555 E:1560 ||| IN
destabilize  ||| S:1560 E:1572 ||| VBG
the  ||| S:1572 E:1576 ||| DT
fold  ||| S:1576 E:1581 ||| NN
led  ||| S:1581 E:1585 ||| VBD
to  ||| S:1585 E:1588 ||| TO
severe  ||| S:1588 E:1595 ||| JJ
genotypes  ||| S:1595 E:1605 ||| NNS
resulting  ||| S:1605 E:1615 ||| VBG
in  ||| S:1615 E:1618 ||| IN
lethal  ||| S:1618 E:1625 ||| JJ
phenotypes ||| S:1625 E:1635 ||| NN
,  ||| S:1635 E:1637 ||| ,
whereas  ||| S:1637 E:1645 ||| IN
the  ||| S:1645 E:1649 ||| DT
mutations  ||| S:1649 E:1659 ||| NN
lying  ||| S:1659 E:1665 ||| VBG
away  ||| S:1665 E:1670 ||| RP
from  ||| S:1670 E:1675 ||| IN
the  ||| S:1675 E:1679 ||| DT
active  ||| S:1679 E:1686 ||| JJ
site  ||| S:1686 E:1691 ||| NN
were  ||| S:1691 E:1696 ||| VBD
milder  ||| S:1696 E:1703 ||| JJR
in  ||| S:1703 E:1706 ||| IN
both  ||| S:1706 E:1711 ||| PDT
their  ||| S:1711 E:1717 ||| PRP$
genotypic  ||| S:1717 E:1727 ||| NN
and  ||| S:1727 E:1731 ||| CC
phenotypic  ||| S:1731 E:1742 ||| JJ
expression ||| S:1742 E:1752 ||| NN
.  ||| S:1752 E:1754 ||| .
Based  ||| S:1754 E:1760 ||| VBN
on  ||| S:1760 E:1763 ||| IN
the  ||| S:1763 E:1767 ||| DT
co-location  ||| S:1767 E:1779 ||| JJ
of  ||| S:1779 E:1782 ||| IN
mutations  ||| S:1782 E:1792 ||| NNS
from  ||| S:1792 E:1797 ||| IN
different  ||| S:1797 E:1807 ||| JJ
organisms  ||| S:1807 E:1817 ||| NNS
and  ||| S:1817 E:1821 ||| CC
their  ||| S:1821 E:1827 ||| PRP$
proximity  ||| S:1827 E:1837 ||| NN
to  ||| S:1837 E:1840 ||| TO
the  ||| S:1840 E:1844 ||| DT
enzyme  ||| S:1844 E:1851 ||| JJ
active  ||| S:1851 E:1858 ||| JJ
site ||| S:1858 E:1862 ||| NN
,  ||| S:1862 E:1864 ||| ,
we  ||| S:1864 E:1867 ||| PRP
have  ||| S:1867 E:1872 ||| VBP
extrapolated  ||| S:1872 E:1885 ||| VBN
observed  ||| S:1885 E:1894 ||| JJ
mutations  ||| S:1894 E:1904 ||| NNS
from  ||| S:1904 E:1909 ||| IN
one  ||| S:1909 E:1913 ||| CD
species  ||| S:1913 E:1921 ||| NNS
to  ||| S:1921 E:1924 ||| TO
homologous  ||| S:1924 E:1935 ||| VB
positions  ||| S:1935 E:1945 ||| NNS
in  ||| S:1945 E:1948 ||| IN
other  ||| S:1948 E:1954 ||| JJ
organisms ||| S:1954 E:1963 ||| NNS
,  ||| S:1963 E:1965 ||| ,
as  ||| S:1965 E:1968 ||| IN
a  ||| S:1968 E:1970 ||| DT
predictive  ||| S:1970 E:1981 ||| JJ
approach  ||| S:1981 E:1990 ||| NN
for  ||| S:1990 E:1994 ||| IN
detecting  ||| S:1994 E:2004 ||| VBG
likely  ||| S:2004 E:2011 ||| JJ
alpha-mannosidosis ||| S:2011 E:2029 ||| NN
.  ||| S:2029 E:2031 ||| .
Besides  ||| S:2031 E:2039 ||| IN
predicting  ||| S:2039 E:2050 ||| VBG
new  ||| S:2050 E:2054 ||| JJ
disease  ||| S:2054 E:2062 ||| NN
mutations ||| S:2062 E:2071 ||| NNS
,  ||| S:2071 E:2073 ||| ,
this  ||| S:2073 E:2078 ||| DT
approach  ||| S:2078 E:2087 ||| NN
also  ||| S:2087 E:2092 ||| RB
provides  ||| S:2092 E:2101 ||| VBZ
a  ||| S:2101 E:2103 ||| DT
way  ||| S:2103 E:2107 ||| NN
for  ||| S:2107 E:2111 ||| IN
detecting  ||| S:2111 E:2121 ||| JJ
mutation  ||| S:2121 E:2130 ||| NN
hotspots  ||| S:2130 E:2139 ||| NN
in  ||| S:2139 E:2142 ||| IN
the  ||| S:2142 E:2146 ||| DT
gene ||| S:2146 E:2150 ||| NN
,  ||| S:2150 E:2152 ||| ,
where  ||| S:2152 E:2158 ||| WRB
novel  ||| S:2158 E:2164 ||| JJ
mutations  ||| S:2164 E:2174 ||| NNS
could  ||| S:2174 E:2180 ||| MD
be  ||| S:2180 E:2183 ||| VB
implicated  ||| S:2183 E:2194 ||| VBN
in  ||| S:2194 E:2197 ||| IN
disease ||| S:2197 E:2204 ||| NN
.  ||| S:2204 E:2206 ||| .
The  ||| S:2206 E:2210 ||| DT
current  ||| S:2210 E:2218 ||| JJ
study  ||| S:2218 E:2224 ||| NN
has  ||| S:2224 E:2228 ||| VBZ
identified  ||| S:2228 E:2239 ||| VBN
five  ||| S:2239 E:2244 ||| CD
mutational  ||| S:2244 E:2255 ||| CD
hot-spot  ||| S:2255 E:2264 ||| JJ
regions  ||| S:2264 E:2272 ||| NNS
along  ||| S:2272 E:2278 ||| IN
the  ||| S:2278 E:2282 ||| DT
MAN2B1  ||| S:2282 E:2289 ||| JJ
gene ||| S:2289 E:2293 ||| NN
.  ||| S:2293 E:2295 ||| .
Structural  ||| S:2295 E:2306 ||| JJ
mapping  ||| S:2306 E:2314 ||| NN
can  ||| S:2314 E:2318 ||| MD
thus  ||| S:2318 E:2323 ||| RB
provide  ||| S:2323 E:2331 ||| VB
a  ||| S:2331 E:2333 ||| DT
rational  ||| S:2333 E:2342 ||| JJ
approach  ||| S:2342 E:2351 ||| NN
for  ||| S:2351 E:2355 ||| IN
predicting  ||| S:2355 E:2366 ||| VBG
the  ||| S:2366 E:2370 ||| DT
phenotype  ||| S:2370 E:2380 ||| NN
of  ||| S:2380 E:2383 ||| IN
a  ||| S:2383 E:2385 ||| DT
disease ||| S:2385 E:2392 ||| NN
,  ||| S:2392 E:2394 ||| ,
based  ||| S:2394 E:2400 ||| VBN
on  ||| S:2400 E:2403 ||| IN
observed  ||| S:2403 E:2412 ||| JJ
genotypic  ||| S:2412 E:2422 ||| JJ
variations ||| S:2422 E:2432 ||| NNS
.  ||| S:2432 E:2434 ||| .
